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Abstract The purpose of this investigation was to explore the
epidemiology, clinical history and microbiology of
peritonsillar abscess (PTA). A retrospective review of PTA
cases treated at the Department of Otolaryngology, Regional
Specialist Hospital in Radom, Poland between 1st October
2003 and 30th September 2013was undertaken. A total of 111
PTA patients were admitted. The study population consisted
of 57.7 % males and 42.3 % females, with an average age of
31.0 (range 5–78) years. Smokers comprised 22.0 % of the
study group. The seasonal variation of PTA was statistically
insignificant (p=0.45). Recurrent tonsillitis occurred in
35.5 % of patients. In comparison with the rest of the study
populat ion, pat ients with a history of recurrent
pharyngotonsillitis had higher incidence of previous PTA
episodes [odds ratio (OR) 17.8, 95 % confidence interval
(CI) 2.1–148.7, p=0.001]. Also, they were more frequently
treated with antibiotics prior to hospitalisation (OR 4.6, 95 %
CI 2.0–10.9, p=0.0005) and had significantly longer hospital
stay (p=0.03). Bacterial cultures of abscess aspirates were
performed in 40.5 % of patients. Monomicrobial growth was
detected in 77.8 % of aerobic cultures. Streptococcus
pyogenes, growing most frequently in monoculture, was
found in 28.9 % of aerobic cultures. PTA patients with and
without recurrent pharyngotonsillitis differed with regard to
clinical history and course of disease. The percentage of
smokers among PTA patients was lower than that described
in the literature. Monomicrobial growth predominated in PTA
aspirate cultures. S. pyogenes proved to be the most frequent
pathogen.
Introduction
Peritonsillar abscess (PTA), or quinsy, is defined as a collec-
tion of pus located between the tonsillar capsule and the
pharyngeal constrictor muscle. Its aetiology and pathogenesis
have not been fully elucidated [1]. It is considered to be a
purulent complication of acute tonsillitis; however, other path-
ogenic mechanisms, such as obstruction of the supratonsillar
Weber’s glands, have also been proposed [1–3]. Adolescents
and young adults are the most commonly affected [4, 5].
Smoking proved to be associated with significantly increased
risk of PTA [6]. There is no consensus as to whether or not
seasonal variation in PTA incidence exists [2, 5, 7–9]. More-
over, there is much inconsistency regarding the microbiology
of PTAs [1]. The majority of abscesses are polymicrobial
infections, with three bacteria regarded to be key causative
pathogens: Streptococcus pyogenes, Fusobacterium
necrophorum and Streptococcus milleri group [1, 4, 7,
10–13]. Monomicrobial infections, however, have been
reported as well [14, 15]. Management protocols are
lacking, and treatment methods include needle aspira-
tion, surgical drainage or quinsy tonsillectomy combined
with antimicrobial therapy [5, 16, 17]. Since data re-
garding PTA in Poland are scarce [18], the aim of our
work was to explore the PTA epidemiology, clinical
history and microbiology.
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Patients and methods
A retrospective study was performed on PTA cases treated at
the Department of Otolaryngology, Regional Specialist Hos-
pital in Radom, Poland between 1st October 2003 and 30th
September 2013. Radom has a population of 220,000 people
and is located in central Poland. The hospital is the only one in
the city providing full-term otolaryngological medical care.
To perform aerobic cultures, abscess aspirates were inoculated
on sheep blood, chocolate, mannitol salt, MacConkey and
Sabouraud agar plates, and incubated in a carbon dioxide-
enriched atmosphere. Anaerobic cultures were carried out
with the usage of Schaedler agar plates. The media were
incubated for up to 3 days at 37 °C, with the exception of
Sabouraud agar plates, which were incubated at 30 °C. The
identification of species was carried out with the use of routine
microbiological methods. The medical records of all PTA
patients were reviewed to obtain the following data: age,
sex, previous episodes of abscess, past history of recurrent
tonsillitis, seasonality, laterality, smoking and dental status,
antibiotic treatment proceeding admission to the hospital,
length of hospitalisation, neutrophil count and C-reactive
protein value, and results of microbiological examination of
PTA purulent contents. A past history of recurrent tonsillitis
has been specified as three or more, five or more, or seven or
more tonsillitis episodes within the previous 1, 2 or 3 years,
respectively. The study was approved by the Bioethics Com-
mittee at the Medical University of Lublin, Poland.
Statistical analysis
Data processing and analysis were performed using
STATISTICA version 10 (StatSoft, Inc.). The results were
expressed as percentage or mean, median (range). The asso-
ciation between each independent variable was statistically
analysed in different groups. Continuous variables were com-
pared using the non-parametric test (Mann–Whitney U-test)
and categorical variables by Pearson’s Chi-squared or Fisher’s
exact test, as appropriate. Odds ratios (ORs) and their 95 %
confidence intervals (CIs) were calculated. Statistical signifi-
cance was set at p < 0.05.
Results
A total of 111 patients were admitted over the 10-year study
period. The study population consisted of 57.7 % males and
42.3 % females, with an average age of 29.7±12.9 years
(range 5–59 years) and 32.7±15.2 years (range 11–78 years),
respectively. The main procedure undertaken was diagnostic
needle aspiration, followed by abscess incision and drainage
combined with antibiotic therapy. Cefuroxime and
metronidazole were administered as empiric antimicrobial
therapy in most cases. The age and sex distribution among
PTA patients is illustrated in Fig. 1. Table 1 depicts the clinical
and epidemiological characteristics of the study population.
The seasonal variation for PTA incidence was statistically
insignificant (p=0.45, Pearson’s Chi-squared test). There was
no significant association between smoking habits and age
among PTA patients (p=1.0, OR 0.9, 95 % CI 0.3–2.8,
Fisher’s exact test). In the group of patients younger than
40 years old, the percentage of smokers was comparable to
that in the older age group (22.4 % versus 20.8 %). Men were
more frequently smokers thanwomen (27.1% versus 14.6%),
but without reaching statistical significance (p=0.15, OR 2.2,
95 % CI 0.8–6.1, Fisher’s exact test).
Thirty (27.0 %) patients had comorbidities; cardiovascular
(36.7 %), neurologic (13.3 %) and thyroid (13.3 %) disorders
proved to be the most frequent ones. Other comorbidities
included diabetes mellitus, liver and ophthalmic disorders,
peptic ulcer disease, rheumatoid arthritis, leukaemia and
Wilson’s disease. When the PTA patients were divided into
two age groups (<40 years old and older), it turned out that, in
older patients, who comprised 24.3 % (27/111) of the study
group, comorbidities occurred more frequently (OR 4.5, 95 %
CI 1.8–11.4, p=0,0022, Fisher’s exact test) and the dental
status was worse (OR 2.8, 95% CI 1.1–7.4, p=0.044, Fisher’s
exact test).
The clinical and epidemiological characteristics of patients
with a history of recurrent pharyngotonsillitis were compared
with the rest of the study population (Table 2).
In 45 patients (40.5 %), bacterial cultures of abscess aspi-
rates were performed. In 19 of them, both aerobic and anaer-
obic cultures were carried out. In this group, a mixture of
aerobic and anaerobic bacteria was detected in two specimens,
and only anaerobic bacteria (Prevotella oralis) or only aerobic
bacteria were detected in one and 16 samples, respectively.
Monomicrobial growth was observed in samples obtained
from 14 out of 19 patients (73.7 %), and two or three isolates
were yielded in samples collected from three and two patients,
respectively. In the remaining 26 patients, only aerobic culture
was performed. Monomicrobial growth was observed in sam-
ples obtained from 21 out of 26 patients (80.8 %). In samples
collected from five patients, two isolates were yielded.
In nine out of 45 aerobic cultures (20.0 %), polymicrobial
growth was observed. In 15 aerobic cultures (33.3 %), only
species belonging to normal oropharynx flora were detected,
namely Streptococcus mitis (one isolate), Streptococcus oralis
(four isolates), Streptococcus salivarius (three isolates), Strep-
tococcus sanguinis (one isolate) and other viridans strepto-
cocci, excluding those belonging to Streptococcus milleri
group (ten isolates). Potential pathogens were identified in
29 aerobic cultures (64.4 %). The most frequently isolated
pathogen proved to be S. pyogenes, found in 13 out of 45
aerobic cultures (28.9 %). It was most frequently isolated as
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monoculture (10/13, 76.9 %). In three cultures, S. pyogenes
was detected as one of two isolates, together with
Enterococcus sp., Escherichia coli and S. salivarius, respec-
tively. Microbial species isolated from PTA aspirate aerobic
and anaerobic cultures are shown in Table 3.
Among 45 patients in whom bacterial cultures of abscess
aspirates were performed, 25 (55.6 %) received antibiotic
therapy prior to admission. Differences were observed in the
isolation of potential pathogens between patients with and
without prior antibiotic therapy, although they were not statis-
tically significant. However, from patients who did not receive
antibiotic therapy prior to admission, potential pathogens were
isolated more frequently than normal oropharynx flora (OR
4.5, 95 % CI 1.0–19.2, p=0.05, Fisher’s exact test). Also,
when S. pyogenes was analysed separately from other poten-
tial pathogens, it turned out that a significantly higher inci-
dence of its isolates were observed in patients without prior
antibiotic therapy (OR 2.1, 95 % CI 1.1–4.0, p=0.037, Fish-
er’s exact test).
Two patients (1.8 %) have bilateral PTA. Both were treated
with antibiotics before admission to the hospital. They did not
have any comorbidities; however, one of them was in early
pregnancy at the time of hospitalisation. In only one of them
was aerobic culture of abscess purulent contents performed
and normal oropharynx flora isolated.
All but two patients recovered without complications. In
one of them, with left-side PTA and S. pyogenes detected in
abscess pus, neck phlegmon occurred. In the second patient,
with left-side PTA and both Acinetobacter baumannii and
Enterococcus faecalis isolated from abscess aspirate aerobic
culture, neck phlegmon and sepsis developed. Both patients
were transferred to the Intensive Care Department and, after
being treated there, recovered.
Discussion
This study characterises several facets of PTA epidemiology,
as well as its clinical history and microbiology.
PTA is a disease usually affecting teenagers and young
adults; its incidence is rare in infants and children. The ma-
jority of studies report male predominance; however, equal
male-to-female ratios have been described as well [5, 7, 8, 10,
12, 13, 19–23]. In our series, the male-to-female ratio proved
to be 1.4:1 and the majority of cases occurred in patients at the






















Fig. 1 Age and sex distribution among patients with peritonsillar abscess (PTA) hospitalised at the Department of Otolaryngology, Regional Specialist
Hospital in Radom, Poland between 1st October 2003 and 30th September 2013





31.0, 27.0 (5–78 years)
Gender Female 47 (42.3)
Male 64 (57.7)
Dental statusa Healthy teeth (1) 24 (24.0)










Abscess side/laterality Left 68 (61.3)
Right 41 (36.9)
Bilateral 2 (1.8)
Previous PTA episodes 9 (8.1)

















Values are numbers (%), unless stated otherwise
PTA peritonsillar abscess,CRPC-reactive protein,WBCwhite blood cells
a, b, c, d Data available for 100, 110, 93 and 105 patients, respectively
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comprised 24.3 % of the study group. Similar percentages of
older patients, namely 24.4 % and 25 %, were reported by
Marom et al. [7] and Matsuda et al. [21], respectively. We
noticed that, in this age group, comorbidities occurred
significantly more frequently and the dental status of patients
proved to be significantly worse as compared with patients
younger than 40 years old. Among our patients, the left tonsil
proved to be affected more frequently. A similar laterality
distribution was found in the studies carried out in Spain and
Northern Ireland [19, 22]. However, equal numbers of left and
right PTA have also been reported [5, 7]. The average inci-
dence of bilateral PTA has been estimated to be 4.8–4.9 %
[24]. In our series, bilateral PTA was found in 1.8 % of
patients. A similar rate of bilateral PTA, namely 1.0 %, was
detected in the study conducted in Singapore [5], whereas
other works reported bilateral PTA in up to 0.8 % of patients
[7, 9, 19]. Previous PTA episodes were present in 8.1 % of our
study population, whereas other studies reported them in
between 11 % and 16 % of their patients [7, 19, 22]. In our
series, previous PTA episodes proved to occur more frequent-
ly in patients with a history of recurrent pharyngotonsillitis
(OR 17.8, 95 % CI 2.1–148.7, p=0.0011).
Although seasonal variation in PTA incidence has been
reported previously, there was no consensus among studies
with respect to the seasonal trend direction.Winter, spring and
autumn peaks were observed [2, 5, 7, 9]. By contrast, in a
recent study carried out in Denmark [8], as well as in our
work, the seasonal variation of PTA proved to be statistically
insignificant.
Smoking habits among PTA patients were analysed in
several studies [6, 7, 13, 25, 26]. In a recent Danish study,
smoking proved to be associated with significantly increased
Table 2 Clinical and epidemiological characteristics of patients with a history of recurrent pharyngotonsillitis compared with the rest of the study
population
Characteristic Recurrent pharyngotonsillitis in the past (% in group) p-Value
Yes (n=39) No (n=71)
Age <40 years 32 (82.1) 51 (71.8) 0.25
Male 21 (53.8) 42 (59.2) 0.69
Smokers 6 (16.7) 16 (25.4) 0.45
Dental status 3–4 15 (40.5) 20 (32.3) 0.52
Left side PTA 26 (66.7) 41 (59.4) 0.54
Previous PTA episodes 8 (20.5) 1 (1.4) 0.001*
Seasonal presentation: Winter 11 (28.2) 14 (19.7) 0.61
Spring 10 (25.6) 16 (22.5)
Summer 11 (28.2) 22 (31.0)
Autumn 7 (18.0) 19 (26.8)
Median (range) hospital stay 5.0 (1−12) 4.0 (1−17) 0.03*
Median (range) CRP value (mg/L) 95.6 (3.5−300.0) 73.0 (6.1−338.0) 0.52
Median (range) WBC value (×103/μl) 14.6 (9.0−61.3) 14.7 (4.4−35.2) 0.77
Antibiotic therapy prior to admission 27 (69.2) 25 (35.2) 0.0005*
Comorbidities 12 (30.8) 18 (25.4) 0.66
PTA peritonsillar abscess, CRP C-reactive protein, WBC white blood cells
*Statistically significant
Table 3 Microbial species isolated from peritonsillar abscess (PTA)
aspirate aerobic and anaerobic cultures
Species No. of positive cultures
Aerobic 44/45
Streptococcus pyogenes 13















a Excluding Streptococcus milleri group
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risk of PTA in both males and females [6]. Marom et al. [7],
Klug et al. [6] and Hidaka et al. [13] reported, respectively,
33.7 %, 36 % and 69 % of smokers among PTA patients.
According to Dilkes et al. [25], PTA patients are 70 % more
likely to smoke than the general population. Surprisingly, in
our series, smokers comprised only 22.0% of the study group.
However, this result may have been biased by the fact that data
regarding smoking status were available for 90.1 % of our
patients. Moreover, only current smoking status declared by
patients was involved in the patient records. For most of them,
the information about past smoking habits was not provided.
Klug et al. [6] found that smoking PTA patients are older than
non-smoking patients; however, we did not find a significant
association between smoking habits and age among our study
population (p=1.0, OR 0.9, 95 % CI 0.3–2.8).
Recurrent tonsillitis has been considered to be important in
PTA pathogenesis [5]. However, it was reported to be present in
the medical history of 12–37.4% of PTA patients [5, 9, 12, 19].
In our study, the percentage of patients with recurrent tonsillitis
proved to be 35.5 %. In this group, we noted a significantly
higher incidence of previous PTA episodes as well as longer
hospital stay in comparison with the remaining patients. Also,
among patients with recurrent tonsillitis, significantly more
cases were treated with antibiotics prior to hospitalisation in
comparison with the rest of the study population. Recently,
Powell et al. [1] hypothesised that there are presumably two
pathogenically distinct PTA subtypes. Type 1 occurs in patients
without recurrent pharyngotonsillitis and contains a pure cul-
ture of a single organism, most frequently S. pyogenes. Type 2,
in turn, is associated with a history of recurrent tonsillitis and
displays polymicrobial growth, often containing anaerobes.
Type 2 has more severe clinical presentation, associated with
chronic underlying microfloral imbalance due to previous an-
tibiotic use. Our findings show that PTA patients with and
without recurrent tonsillitis differed with regard to clinical
history and course of disease. We did not find differences in
the microbiological profile of aspirate cultures among patients
with and without recurrent tonsillitis; however, this could be
due to the fact that microbiological examination was performed
in only 40.5 % of the study population.
The majority of reported PTAs are polymicrobial infections
[1, 4, 7, 10–13]. However, in the work carried out by Snow
et al. [15], 72.3 % of patients proved to have monomicrobial
infection. Also, Megalamani et al. [14] identified
monomicrobial growth in 65 % of their aerobic cultures. In
our work, monomicrobial growth in PTA cultures predomi-
nated as well. It was observed in samples obtained from
73.7 % of patients in whom both aerobic and anaerobic
cultures were performed, as well as from 80.8 % of those in
whom only aerobic culture was carried out. However, since
complete microbiological examination of PTA aspirates was
performed in only a small number of our patients, these results
should be interpreted with caution.
Three bacteria are regarded to be key causative pathogens
in PTA: Streptococcus pyogenes , Fusobacterium
necrophorum and Streptococcus milleri group, including
S. intermedius, S. anginosus and S. constellatus [1, 4, 7,
10–13]. We considered Streptococcus viridans other than
S. milleri group to be normal oropharynx flora and all other
bacterial species to be potential pathogens. S. pyogenes, one of
the most prominent PTA pathogens, proved to be isolated
from between 20 % and 30 % or approximately 45 % of PTAs
[1, 7, 10, 12, 20]. It was growing more frequently as a sole
isolate than in mixed culture [14, 15, 20, 22, 27]. In our work,
S. pyogenes growing most often as monoculture was found in
28.9 % of aerobic cultures. It proved to be the most frequently
isolated pathogen, followed by S. anginosus, S. constellatus
and Prevotella sp. However, viridans streptococci other than
S. milleri group were isolated from 35.5% of aerobic cultures.
Since PTA patients are frequently at different stages of anti-
microbial therapy at the time of presentation (46.8 % of our
patients were), abscess aspirate cultures may not necessarily
represent the actual causative organism(s). Some studies re-
ported no significant difference in the cultured bacteria be-
tween patients with and without prior antibiotic treatment [14,
23, 28]. In our work, differences observed in the isolation of
potential pathogens between patients with and without prior
antibiotic therapy were not statistically significant as well.
However, potential pathogens were isolated more frequently
than normal oropharynx flora from patients who did not
receive antibiotic therapy prior to admission (OR 4.5, 95 %
CI 1.0–19.2, p=0.05). Also, we observed a significantly
higher incidence of S. pyogenes isolates in patients without
antibiotic therapy prior to PTA presentation, which is in
accordance with several previous reports [7, 20, 29, 30]. Thus,
it is possible that S. pyogenes can be the causative pathogen in
many more PTA cases than those in which it has been isolated
in abscess aspirate culture. On the other hand, however, the
percentages of S. pyogenes isolations in patients without prior
antibiotic treatment in the study carried out by Megalamani
et al. [14] proved to be similar to those observed in patients
who were treated with antibiotics before PTA presentation.
Summarising, we found that PTA patients with and without
recurrent pharyngotonsillitis differed with regard to clinical
history and course of disease. The percentage of smokers was
lower than that described in the literature. Monomicrobial
growth predominated in PTA aspirate cultures. S. pyogenes
proved to be the most frequent pathogen. The strength of our
study is the careful analysis of epidemiological, clinical and
microbiological data in a relatively large group of PTA pa-
tients. However, it has several limitations. One of them is its
retrospective nature. Moreover, bacteriologic examination
was carried out in a small number of patients, and in an even
smaller percentage it was complete, i.e. both aerobic and
anaerobic cultures of PTA aspirate were performed. Thus,
solid conclusions regarding PTA microbiology are difficult
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to draw. Prospective studies, carried out according to a unified
protocol including complete bacteriologic PTA aspirate ex-
amination, would be indicated in order to find out whether or
not there are differences regarding the microbiological profile
in patients with and without a history of recurrent
pharyngotonsillitis.
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